Clinical Trials Browser

Phase 2 × Triple Negative Breast Neoplasms × Gefitinib × Clear all

NCT01732276 2012-12-03

The Safety and Effects of Gefitinib in Triple-negative,EGFR Positive Metastatic Breast Cancer

Phase 2 Unknown

Breast Neoplasms, Triple Negative Breast Neoplasms